KR900701827A - 치료용 펩타이드 - Google Patents

치료용 펩타이드

Info

Publication number
KR900701827A
KR900701827A KR1019900701287A KR900701287A KR900701827A KR 900701827 A KR900701827 A KR 900701827A KR 1019900701287 A KR1019900701287 A KR 1019900701287A KR 900701287 A KR900701287 A KR 900701287A KR 900701827 A KR900701827 A KR 900701827A
Authority
KR
South Korea
Prior art keywords
active site
binding
peptide
receptor
analog
Prior art date
Application number
KR1019900701287A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/282,328 external-priority patent/US5162497A/en
Application filed filed Critical
Publication of KR900701827A publication Critical patent/KR900701827A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57572—Gastrin releasing peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C07K7/086—Bombesin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1019900701287A 1988-10-14 1990-06-15 치료용 펩타이드 KR900701827A (ko)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US25799888A 1988-10-14 1988-10-14
US07/282,328 US5162497A (en) 1987-09-24 1988-12-09 Bradykinin analogs with non-peptide bond
US31794189A 1989-03-02 1989-03-02
US37655589A 1989-07-07 1989-07-07
US39716989A 1989-08-21 1989-08-21
PCT/US1989/004616 WO1990003980A1 (en) 1988-10-14 1989-10-13 Therapeutic peptides

Publications (1)

Publication Number Publication Date
KR900701827A true KR900701827A (ko) 1990-12-04

Family

ID=27540392

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900701287A KR900701827A (ko) 1988-10-14 1990-06-15 치료용 펩타이드

Country Status (13)

Country Link
EP (1) EP0438519B1 (ko)
JP (1) JP2919889B2 (ko)
KR (1) KR900701827A (ko)
AT (1) ATE165836T1 (ko)
AU (1) AU638423B2 (ko)
DE (1) DE68928667T2 (ko)
DK (1) DK66391A (ko)
FI (1) FI104252B (ko)
HK (1) HK1010785A1 (ko)
HU (1) HU208439B (ko)
MC (1) MC2144A1 (ko)
TW (1) TW201754B (ko)
WO (1) WO1990003980A1 (ko)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2877775A (en) * 1957-12-23 1959-03-17 Preston M Hall Rotary type filing and abrading appliance
US5877277A (en) 1987-09-24 1999-03-02 Biomeasure, Inc. Octapeptide bombesin analogs
AU618029B2 (en) * 1987-11-02 1991-12-12 Imperial Chemical Industries Plc Polypeptide compounds
US6218364B1 (en) 1988-06-20 2001-04-17 Scott L. Harbeson Fluorinated neurokinin A antagonists
US5830863A (en) * 1988-06-20 1998-11-03 Merrell Pharmaceuticals Inc. Neurokinin A antagonists
WO1991004040A1 (en) * 1989-09-15 1991-04-04 Biomeasure, Inc. Treatment of colon cancer
CA2045494A1 (en) * 1989-11-06 1991-05-07 Luigia Gozzini Reduced irreversible bombesin antagonists
AU641789B2 (en) * 1990-07-26 1993-09-30 Aventisub Ii Inc. Peptides
US5834433A (en) * 1990-07-26 1998-11-10 Merrell Pharmaceuticals Inc. Compounds and pharmaceutical uses of peptides of bombesin and GRP
US5369094A (en) * 1990-11-29 1994-11-29 The Administrators Of The Tulane Educational Fund Polypeptide bombesin antagonists
US5244883A (en) * 1990-11-29 1993-09-14 The Administrators Of The Tulane Educational Fund Nonapeptide bombesin antagonists
JP3350701B2 (ja) * 1991-05-23 2002-11-25 メレルダウファーマスーティカルズ インコーポレイテッド ボンベシン類似体類
CA2129032A1 (en) * 1992-02-07 1993-08-19 Judson V. Edwards Phenylalanine analogs of bombesin
DE4320201A1 (de) * 1993-06-18 1995-01-12 Asta Medica Ag Verwendung von Cetrorelix und weiteren Nona- und Dekapeptiden zur Herstellung eines Arzneimittels zur Bekämpfung von Aids und zur Wachstumsstimulation
FR2739553B1 (fr) 1995-10-06 1998-01-02 Oreal Utilisation d'antagonistes de la bradykinine pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
US6492330B1 (en) 1996-08-16 2002-12-10 National Institute Of Immunology Antiangiogenic drugs
US6156725A (en) * 1996-08-16 2000-12-05 National Institute Of Immunology Drug for the treatment of cancer
US8420050B2 (en) 2003-01-13 2013-04-16 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7611692B2 (en) 2003-01-13 2009-11-03 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7850947B2 (en) 2003-01-13 2010-12-14 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7226577B2 (en) 2003-01-13 2007-06-05 Bracco Imaging, S. P. A. Gastrin releasing peptide compounds
US7922998B2 (en) 2003-01-13 2011-04-12 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
NZ576739A (en) 2003-04-22 2011-01-28 Sod Conseils Rech Applic Peptide vectors for delivering paclitaxel
RU2009112716A (ru) * 2006-09-08 2010-10-20 Байер Шеринг Фарма Акциенгезельшафт (DE) Соединения и способы для агентов, меченых 18f
EP2310028B1 (en) 2008-06-12 2016-11-16 Ipsen Bioinnovation Limited Fusion proteins for use in the treatment of acromegaly
CN107446053A (zh) 2008-06-12 2017-12-08 益普生生物创新有限公司 癌症的抑制
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
EP2198878A1 (en) 2008-12-18 2010-06-23 University Of Miami Polypeptide bombesin antagonists
CN116333041A (zh) * 2023-04-10 2023-06-27 湖南中晟全肽生化有限公司 一种激活grp受体的多肽化合物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207311A (en) 1977-07-18 1980-06-10 The Salk Institute For Biological Studies Peptides having analgesic and thermoregulative properties
US4331611A (en) 1979-12-21 1982-05-25 International Flavors & Fragrances Inc. Nitrile and uses of same in perfumes, colognes and perfumed articles
US4331661A (en) * 1980-10-03 1982-05-25 The Salk Institute For Biological Studies Bombesin analogs
US4613586A (en) * 1984-04-19 1986-09-23 Board Of Trustees Of The Leland Stanford Junior University Gastrin releasing peptide-like peptides
US4803261A (en) * 1986-06-27 1989-02-07 The Administrators Of The Tulane Educational Fund Method for synthesizing a peptide containing a non-peptide

Also Published As

Publication number Publication date
TW201754B (ko) 1993-03-11
AU4494989A (en) 1990-05-01
HU208439B (en) 1993-10-28
EP0438519A1 (en) 1991-07-31
EP0438519B1 (en) 1998-05-06
FI104252B1 (fi) 1999-12-15
DE68928667D1 (de) 1998-06-10
DE68928667T2 (de) 1998-10-01
DK66391D0 (da) 1991-04-12
FI911780A0 (fi) 1991-04-12
AU638423B2 (en) 1993-07-01
JPH04504406A (ja) 1992-08-06
HK1010785A1 (en) 1999-06-25
DK66391A (da) 1991-06-14
JP2919889B2 (ja) 1999-07-19
FI104252B (fi) 1999-12-15
HU896391D0 (en) 1991-07-29
HUT59420A (en) 1992-05-28
EP0438519A4 (en) 1991-10-30
MC2144A1 (fr) 1992-02-19
WO1990003980A1 (en) 1990-04-19
ATE165836T1 (de) 1998-05-15

Similar Documents

Publication Publication Date Title
FI911780A0 (fi) Terapeutiska peptider.
NO178306C (no) Analogifremgangsmåte ved fremstilling av bombesin-antagonistpeptid
FI920737A0 (fi) Terapeutiska peptider.
BR9713108A (pt) Colagenase recombinante do tipo i de clostridium histolytucum e o uso da mesma para o isolamento de células e de grupos de células
PT91692A (pt) Processo para a preparacao de peptideos com actividade antagonista da bradiquinina
DE69942365D1 (de) Gezielte zufuhr von pharmazeutischen agenzien zu verletzten geweben
PT94982A (pt) Processo para a preparacao de peptidos com accao antagonista contra bradiquinina e de composicoes farmaceuticas que os contem
EA200000378A1 (ru) Усеченные по амино-концу мср-2 как антагонисты хемокинов
BR9916323A (pt) Inibidores da integrina alfavbeta6
EA200100264A1 (ru) Ангиоцидин: адгезионный рецептор опухолей клетки, специфический для cys-ser-val-thr-cys-gly
LV10108A (lv) Sunu proliferacijas inhibitori farmaceitiska kompozicija savienojumu iegusanas metode sunu proliferacijas inhibesanas panemieni
ATE143372T1 (de) Substance p antagoniste
AR020101A1 (es) Un antagonista peptido del receptor de uroquinasa humana, composicion farmaceutica que lo contiene, su uso para la manufactura de un medicamento y metodopara seleccionar un antagonista peptido adecuado.
ATE107315T1 (de) Menschlicher plazentarer angiogenischer faktor, geeignet für die reizung der kapillarsynthese, der endothelzellprotease, der dns-synthese und der absiedlung.
PT93320A (pt) Processo para a preparacao de peptideos terapeuticos
KR950704358A (ko) 카텝신 l 특이적 저해 폴리펩티드
BR0202157A (pt) Peptìdeo obtido de veneno escorpião para uso como agente hipotensivo
ATE212222T1 (de) Zusammensetzungen zur transdermalen und dermalen verabreichung von biologisch wirksamen stoffen
PE47396A1 (es) Modulador del peso corporal, acido nucleico y proteinas correspondientes y procedimiento de preparacion
PT95057A (pt) Processo para a preparacao de peptidos terapeuticos

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid